OUR COMPANY
CONTACT
Home
Products
How the solution works
UNEEG™ SubQ
24/7 EEG™ SubQ
UNEEG™ MyConnect
UNEEG™ EpiSight
IFU
Clinical Publications
Epilepsy
EEG Research
Diabetes
Epilepsy
EAR-EEG
News and press
News
Events
Media Library
Media / Products
Media / Management
Media / Lifestyle
Press contact
INTRODUCING:
ON DEMAND
ACCESS TO YOUR PATIENTS' EEG
UNEEG™ MyConnect
EPILEPSY:
RELIABLE SEIZURE TRACKING
Ultra long-term, objective seizure* tracking represents a new way forward for epilepsy care, and complements the tools currently available.
Our CE-marked 24/7 EEG™ SubQ solution allows for continuous EEG monitoring day and night for up to 15 months and offers healthcare professionals objective knowledge of seizure activity.
*electrographic seizures
NEWS
UNEEG medical invested in development and commercialisation in 2020/21
Introducing: On demand access to your patients' EEG: UNEEG™ MyConnect
Reliability of ultra long-term subcutaneous EEG: a demonstration of temporal impedance consistency
How will ultra long-term EEG offer value to clinicians and patients with epilepsy
Revolutionary Innovation for the treatment of uncontrolled epilepsy
First U.S. patient initiated in pivotal multi-center study for U.S. approval of the UNEEG EpiSight™ solution
365 nights of sleep EEG monitoring study - is well underway
NEXT CONGRESSES:
ICTALS, 4-8 July, Bern, Switzerland
European Epilepsy Congress, 9-13 July, Geneva, Switzerland
ICCN, 4-8 September,
Geneva, Switzerland